HCV-IN-37

HCV-IN-37

• CAS Number: 2425804-98-2
• UNSPSC Description: HCV-IN-37 (Compound 3d) is a potent inhibitor of HCV. HCV-IN-37 is orally available and long-lasting in rat plasma after oral administration to rats by a single dose of 15 mg/kg. The high potency of active derivative HCV-IN-37 is primarily driven by the inhibitory effect on the virus entry stage[1].
• Target Antigen: HCV
• Type: Reference compound
• Related Pathways: Anti-infection
• Applications: COVID-19-anti-virus
• Field of Research: Infection
• Assay Protocol: https://www.medchemexpress.com/hcv-in-37.html
• Solubility: 10 mM in DMSO
• Smiles: N#CC1=CC=C(N2CCN(C)CCC2)C=C1CN3CCN(C(C4=CC=C(F)C=C4)C5=CC=C(F)C=C5)CC3
• Molecular Weight: 515.64
• References & Citations: [1]Wang Y, et al. Design, Synthesis, and Biological Evaluation of 2-((4-Bisarylmethyl-piperazin-1-yl)methyl)benzonitrile Derivatives as HCV Entry Inhibitors. J Med Chem. 2022 Feb 10;65(3):2107-2121.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported